Agios Pharmaceutical shares tank amid safety concerns about drug – CNBC


CNBC
Agios Pharmaceutical shares tank amid safety concerns about drug
CNBC
Shares of Agios Pharmaceutical shed 12 percent Monday amid concern about the safety of one of the molecules in its drug to treat pyruvate kinase deficiency, a rare, genetic anemia. The company reported that one patient saw a serious adverse event after …

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd